HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 172 filers reported holding HAEMONETICS CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,358,000 | -18.8% | 59,700 | -16.6% | 0.02% | -22.2% |
| Q1 2017 | $2,905,000 | +0.9% | 71,600 | 0.0% | 0.03% | -3.6% |
| Q4 2016 | $2,878,000 | +3.7% | 71,600 | -6.5% | 0.03% | +16.7% |
| Q3 2016 | $2,774,000 | +24.9% | 76,600 | 0.0% | 0.02% | +26.3% |
| Q2 2016 | $2,221,000 | +0.6% | 76,600 | +21.4% | 0.02% | 0.0% |
| Q1 2016 | $2,207,000 | +8.5% | 63,100 | 0.0% | 0.02% | +11.8% |
| Q4 2015 | $2,034,000 | +11.0% | 63,100 | +11.3% | 0.02% | +6.2% |
| Q3 2015 | $1,833,000 | +11.1% | 56,700 | +42.1% | 0.02% | +23.1% |
| Q2 2015 | $1,650,000 | -54.0% | 39,900 | -50.0% | 0.01% | -51.9% |
| Q1 2015 | $3,585,000 | +57.9% | 79,800 | +31.5% | 0.03% | +50.0% |
| Q4 2014 | $2,271,000 | +7.1% | 60,700 | 0.0% | 0.02% | +5.9% |
| Q3 2014 | $2,120,000 | – | 60,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |